Access the full text.
Sign up today, get DeepDyve free for 14 days.
Moon Choi, J. Choi, Jeeyun Lee, J. Heo, S. Choi, D. Choi, Kyu Lee, J. Lee, K. Lee, Joon-Oh Park, Y. Park, Ho Lim (2014)
Prognostic and predictive value of metabolic tumor volume on 18F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinibMedical Oncology, 31
Hyoungwoo Kim, I. Yoo, S. Boo, H. Park, J. O, S. Kim (2018)
Prognostic Value of Pre- and Post-Treatment FDG PET/CT Parameters in Small Cell Lung Cancer PatientsNuclear Medicine and Molecular Imaging, 52
Young Chung, D. Choi, S. Choi, J. Heo, D. Kim (2013)
Prognostic factors following surgical resection of distal bile duct cancerJournal of the Korean Surgical Society, 85
E. Lee, Seong-Hwan Chang, T. Lee, S. Yoon, Y. Cheon, C. Shim, Y. So, H. Chung (2015)
Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma.Anticancer research, 35 12
Nataliya Razumilava, Gregory Gores (2014)
CholangiocarcinomaThe Lancet, 383
Min-Su Park, Sang-Mok Lee (2014)
Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.Anticancer research, 34 5
Jang Yoo, J. Choi, Kyu Lee, J. Heo, Soo Park, S. Moon, Y. Choe, Kyung-Han Lee, Byung‐Tae Kim (2012)
Prognostic Significance of Volume-based Metabolic Parameters by 18F-FDG PET/CT in Gallbladder CarcinomaNuclear Medicine and Molecular Imaging, 46
J. Cho, Ho-Seong Han, Yoo-Seok Yoon, D. Hwang, K. Jung, J. Kim, Yujin Kwon, Haeryoung Kim (2012)
Preoperative Cholangitis and Metastatic Lymph Node Have a Negative Impact on Survival After Resection of Extrahepatic Bile Duct CancerWorld Journal of Surgery, 36
C. Moon, Seungmin Bang, J. Chung (2011)
The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.Surgical oncology, 20 1
K. Cho, D. Oh, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, S. Im, Tae-You Kim, Y. Bang (2015)
Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.The oncologist, 20 8
A. Nakeeb, H. Pitt, T. Sohn, J. Coleman, R. Abrams, S. Piantadosi, R. Hruban, K. Lillemoe, C. Yeo, J. Cameron (1996)
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.Annals of surgery, 224 4
Masayuki Akita, T. Ajiki, Taku Matsumoto, K. Shinozaki, T. Goto, S. Asari, H. Toyama, M. Kido, T. Fukumoto, Y. Ku (2017)
Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct CancerJournal of Gastrointestinal Surgery, 21
Ji Lee, Hongyong Kim, Seo-Hyung Yim, D. Shin, Jung-hee Yu, D. Ju, J. Park, D. Park, Y. Cho, C. Sohn, W. Jeon, B. Kim (2013)
Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 62 4
Jeong-Yeop Song, Y. Lee, Y. Kim, Sang Kim, S. Jin, J. Park, G. Choi, J. Chung, Min Lee, Youn Cho, M. Choi, D. Kim, H. Choi, J. Moon, Se Lee, S. Jeong, J. Jang, Hong Kim, B. Kim (2015)
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumorsNuclear Medicine Communications, 36
W. Jarnagin, W. Bowne, D. Klimstra, L. Ben-Porat, K. Roggin, K. Cymes, Y. Fong, R. DeMatteo, M. D'Angelica, J. Koea, L. Blumgart (2005)
Papillary Phenotype Confers Improved Survival After Resection of Hilar CholangiocarcinomaAnnals of Surgery, 241
J. Hwang, I. Lim, I. Na, E. Cho, B. Kim, C. Choi, S. Lim (2013)
Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder CancerNuclear Medicine and Molecular Imaging, 48
J. Everhart, C. Ruhl (2009)
Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.Gastroenterology, 136 4
Al Benson, Thomas Abrams, E. Ben-Josef, P. Bloomston, Jean Botha, Bryan Clary, A. Covey, Steven Curley, Michael D'Angelica, Rene Davila, William Ensminger, John Gibbs, D. Laheru, M. Malafa, J. Marrero, Steven Meranze, Sean Mulvihill, James Park, James Posey, J. Sachdev, R. Salem, Elin Sigurdson, C. Sofocleous, J. Vauthey, A. Venook, Laura Goff, Y. Yen, Andrew Zhu (2009)
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.Journal of the National Comprehensive Cancer Network : JNCCN, 7 4
Yeon-Soo Lee, I. Yoo, S. Boo, Hyoungwoo Kim, H. Park, Joo O (2017)
The Role of F-18 FDG PET/CT in Intrahepatic CholangiocarcinomaNuclear Medicine and Molecular Imaging, 51
Su Lee, J. Choi, H. Lee, C. Baek, Y. Son, S. Hyun, S. Moon, Byung‐Tae Kim (2012)
Prognostic Value of Volume-Based 18F-Fluorodeoxyglucose PET/CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell CarcinomaKorean Journal of Radiology, 13
Shin Hwang, Young‐Joo Lee, G. Song, Kwang-Min Park, Ki‐Hun Kim, C. Ahn, D. Moon, Sung‐Gyu Lee (2015)
Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 CasesJournal of Gastrointestinal Surgery, 19
J. Hwang, I. Lim, K. Chang, Byung Kim, C. Choi, S. Lim (2012)
Prognostic value of SUVmax measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Pancreatic CancerNuclear Medicine and Molecular Imaging, 46
Purpose As there were few previous studies with a small number of subjects, the purpose of this was to evaluate the prognostic significance of F-FDG PET/CT in patients with distal bile duct cancer undergoing curative surgery. Methods The study included 40 patients (M/F = 24:16; age 68.0 ± 8.0 years) who underwent preoperative F-FDG PET/CT followed by curative surgical resection. The participant’s age, sex, Eastern Cooperative Oncology Group performance-status score, baseline serum CA 19-9 level, stage, pathologic T and N stages, tumor size, tumor grade, tumor growth pattern, R0 resection, and adjuvant therapy were included as clinicopathological variables for predicting overall survival. The PET variables were maximum standardized uptake value (SUV ), average SUV (SUV ), metabolic tumor volume (MTV), and total lesion max avg glycolysis (TLG) of the tumor. The Kaplan-Meyer method and Cox proportional hazards model were used for the survival analysis. Results A total of 15 of 40 patients (37.5%) died during the follow-up period. In univariate analysis, low SUV (≤ 2.7, p = max 0.0005) and low SUV (≤ 2.6, p = 0.0034) were significant predictors of poor overall survival. In multivariate analyses, only avg low SUV (HR = 6.7016, 95% CI 1.9961–22.4993, p =
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Aug 30, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.